The Hong Kong Association of The Pharmaceutical Industry (HKAPI) held its Annual General Meeting on 2 April 2020 and delighted to announce the formation of the New Board (2020 – 2022) with following members:
President Dr Daniel THURLEY 總經理 羅氏大藥廠香港有限公司
Vice President Ms. Dorine LEUNG General Manager & Country Vice President Novartis Pharmaceuticals (HK) Ltd.
Board of Directors (by alphabetical order of their surname) Ms Kara CHEUNG General Manager, Hong Kong & Macau Amgen Hong Kong Limited
Mr FONG Wai-ting Head of Country Management & Vice President, Healthcare Medinova AG
Ms Peggy FUNG General Manager, Pharmaceuticals – Hong Kong & Macau GlaxoSmithKline Ltd.
Mr Alex HO 總經理 Janssen, Johnson & Johnson (HK) Limited
Mr Gwenaël MENEUX General Manager, Hong Kong & Macau AstraZeneca Hong Kong Limited
Mr Richard SUN General Manager, HK, Malaysia & Singapore AbbVie Limited
Mr Lawrence WONG General Manager, Hong Kong Ferring Pharmaceuticals Limited
While congratulating the new Board members on board, we also thank those Board members served in 2018 -2020 for their remarkable leadership, time and effort for serving the industry.
In addition, we shall thank for all taskforce leads and taskforce members for their valuable contribution and passion to work for the strategic initiatives and for the system betterment in the past two years.
With those collective wisdom and effort, the HKAPI is able to continue bringing visible achievements in driving expedient access to innovative healthcare solutions for the people of Hong Kong and Macao with high ethical standard.